New approach aims to boost HIV prevention in LGBTQ+ individuals struggling with addiction

NCT ID NCT05934877

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program to help HIV-negative transgender women and men who have sex with men who also have a substance use disorder stick with PrEP, a daily pill or shot that prevents HIV. Participants received counseling and text support, with extra help for those who struggled. The goal was to see if this stepped-care approach improves PrEP use and is cost-effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Friends Community Center

    Los Angeles, California, 90038, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.